Interrupting immune-suppressing treatment can boost COVID vaccine response
A brief interruption in treatment for people who use immune-suppressing medicine can double the antibody response to COVID-19 booster vaccination.
Feature
How can a human challenge study help tackle the global impact of Salmonella?
Dr Malick Gibani explains how a human challenge study for non-typhoidal Salmonella can support vaccine development and protect vulnerable populations.
£3m NIHR funding boost for digital diagnostics in African healthcare systems
A new £3m NIHR award will see Imperial and 13 institutions collaborate to research and develop digital diagnostics for African healthcare systems.
Omicron infection is a poor booster of COVID-19 immunity
People infected with the Omicron variant show poor immune boosting against future SARS-CoV-2 infection.
10
Blood pressure control and mask immunotherapy: News from the College
Here’s a batch of fresh news and announcements from across Imperial.
Arctic clouds and harnessing light: News from the College
Here’s a batch of fresh news and announcements from across Imperial.
Feature
Hepatitis outbreak in children: What do we know so far?
Scientists and healthcare professionals around the world are continuing to investigate a sudden increase in hepatitis cases in children.
1
T cells block nerve cell regeneration with age, but can be reversed – mice study
New research in mice shows T cells prevent damaged nerve cells from regenerating due to a reversible, ageing-related mechanism.
Six Imperial researchers awarded AMS Fellowships
Six Imperial researchers have been elected to the Fellowship of the Academy of Medical Sciences for their outstanding work in their fields.
Ongoing ‘immune injuries’ might cause persistent breathlessness after COVID-19
Long-lasting immune activity in the airways might be the cause of persistent breathlessness following COVID-19.
